CanSinoBIO lists successfully on STAR Market as Initial dual listing vaccine company

China |  News | 0 Comment | 14 Aug, 2020

China's CanSino Biologics Inc. announced on 13 August 2020 that it has successfully listed on the Sci-Tech Innovati...Read more

Viva Biotech acquires major stake in Chinese CDMO

China |  News | 0 Comment | 14 Aug, 2020

Viva Biotech (Shanghai) Co., Ltd. has entered into the Share Purchase Agreement pursuant to which Viva Biotech agreed to...Read more

Antengene announces approval of first Ph I Trial of ATG-017

China |  News | 0 Comment | 13 Aug, 2020

Shanghai-based Antengene Corporation, leading innovative hematology and oncology-focused biopharmaceutical company, anno...Read more

SCMP’s China Healthcare Report reveals World’s Second-Largest Healthcare Market

China |  News | 0 Comment | 13 Aug, 2020

South China Morning Post announced on 13 August 2020 the release of its inaugural China Healthcare Report that...Read more

Innovent & Lilly announce acceptance of new drug application for TYVYT® (sintilimab injection)

China |  News | 0 Comment | 12 Aug, 2020

China-based Innovent Biologics, Inc. (Innovent), jointly announced with Eli Lilly and Company (Lilly) that the National ...Read more

LianBio to extend cutting-edge therapeutics in China and major Asian market

China |  News | 0 Comment | 12 Aug, 2020

LianBio, founded, seeded and incubated by Perceptive Advisors, announced its launch on 11 August 2020 with a diverse arr...Read more

Asclepius Meditec's hydrogen/oxygen generator helps improve COVID-19 severity

China |  News | 0 Comment | 11 Aug, 2020

An innovative, environmentally friendly treatment with no side effects has been made available to COVID-19 patients, inv...Read more

Hong Kong discovers liver injury in COVID-19 patients

China |  News | 0 Comment | 12 Aug, 2020

Researchers from the Faculty of Medicine at The Chinese University of Hong Kong (CU Medicine) have recently conducted a ...Read more

Innovent & Lilly release clinical trial results of sintilimab injection

China |  News | 0 Comment | 10 Aug, 2020

China-based Innovent Biologics, Inc. (Innovent), a world-class biopharmaceutical company that develops, manufactures and...Read more

Regulations and geopolitics themes for Japanese companies to reduce dependence on China

China |  Analysis | 0 Comment | 07 Aug, 2020

Regulations, China Impact and Geopolitics were the top themes in 2020 for Japanese companies to reduce dependency on Chi...Read more

ImmVira, Shanghai Pharma to commercialize novel immunotherapies

China |  News | 1 Comment | 07 Aug, 2020

ImmVira Group Company and Shanghai Pharmaceuticals Holding Co., Ltd recently announced a clinical collaboration and excl...Read more

AstraZeneca inks COVID-19 vaccine deal with China's BioKangtai

China |  News | 0 Comment | 07 Aug, 2020

AstraZeneca signed a deal with Beijing-based Shenzhen Kangtai Biological Products (BioKangtai) ...Read more

HBM collaborates with Viva Biotech to promote biotech start-ups

China |  News | 0 Comment | 05 Aug, 2020

  Harbour BioMed (HBM), a global clinical-stage biopharmaceutical company based in the US and Shanghai-based Viva ...Read more

G1, Simcere to bring new cancer therapy in Greater China

China |  News | 0 Comment | 06 Aug, 2020

US based G1 Therapeutics, Inc., a clinical-stage oncology company, and Simcere Pharmaceutical Group, a pharmaceutic...Read more

Innovent announces first patient dosed in Ph 1 clinical trial of bispecific antibody

China |  News | 0 Comment | 03 Aug, 2020

Innovent Biologics, Inc. (Innovent), a world-class biopharmaceutical Chinese company that develops, manufactures and com...Read more

Gan & Lee launches first Ph I clinical trial for new anti-tumor drug

China |  News | 0 Comment | 31 Jul, 2020

Recently, Chinese company Gan & Lee Pharmaceuticals Co., Ltd. (Gan & Lee), has launched their first Phase 1 huma...Read more

Hisun's Favipiravir supports Middle East in fighting COVID-19

China |  News | 0 Comment | 31 Jul, 2020

  According to the Middle East News Agency, Favipiravir, the popular drug used for treating COVID-19 has shown exc...Read more

Viva Biotech, Schrödinger focus on structure-based drug discovery

China |  News | 0 Comment | 31 Jul, 2020

China based Viva Biotech Holdings and Schrödinger, Inc. in the US have announced a strategic collaboration to ...Read more